Startup’s tablets deliver cancer drugs more evenly over time
An MIT team’s technology could allow cancer drugs to be delivered more steadily into the bloodstream, to improve effectiveness and reduce side effects.
An MIT team’s technology could allow cancer drugs to be delivered more steadily into the bloodstream, to improve effectiveness and reduce side effects.
Their system uses electrochemically generated bubbles to detach cells from surfaces, which could accelerate the growth of carbon-absorbing algae and lifesaving cell therapies.
Co-founded by an MIT alumnus, Watershed Bio offers researchers who aren’t software engineers a way to run large-scale analyses to accelerate biology.
MIT CSAIL and McMaster researchers used a generative AI model to reveal how a narrow-spectrum antibiotic attacks disease-causing bacteria, speeding up a process that normally takes years.
A new study finds over half the drugs approved this century cite government-funded research in their patents.
By enabling rapid annotation of areas of interest in medical images, the tool can help scientists study new treatments or map disease progression.
Advance from SMART will help to better identify disease markers and develop targeted therapies and personalized treatment for diseases such as cancer and antibiotic-resistant infection.
A system conceived in Professor Michael Cima’s lab was approved by the Food and Drug Administration after positive results in patients.
Tom Zeller’s new book, “The Headache,” sheds light on one of the world’s most confounding and agonizing ailments.
VaxSeer uses machine learning to predict virus evolution and antigenicity, aiming to make vaccine selection more accurate and less reliant on guesswork.
The team used two different AI approaches to design novel antibiotics, including one that showed promise against MRSA.
The mechanical system could be used to deliver drugs in the GI tract or monitor aquatic environments.
A new approach for testing multiple treatment combinations at once could help scientists develop drugs for cancer or genetic disorders.
The molecules trigger a built-in cellular stress response and show promise as broad-spectrum antivirals against Zika, herpes, RSV, and more.
CellLENS reveals hidden patterns in cell behavior within tissues, offering deeper insights into cell heterogeneity — vital for advancing cancer immunotherapy.